In an interview with NeuroNews, David Volders (Toronto, Canada) gives his perspectives on some of the key trends in the world of aspiration thrombectomy, and outlines multiple technologies that he believes are set to have a positive impact on this area of interventional stroke care.
In addition to the ‘game-changing’ potential of devices like the BMX96 neurovascular access catheter and the benefits of SENDit technology (both Penumbra), Volders also touches on the recent shift away from balloon guide catheters as well as the ‘exciting’ possibilities created by modulated aspiration approaches.
David Volders is an associate professor at the University of Toronto, and an interventional and diagnostic neuroradiologist at Toronto Western Hospital, in Toronto, Canada.
Read the full advertorial HERE.
This video, intended only for audiences outside the USA, is sponsored by Penumbra, Inc.
